US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AgomAb Therapeutics

13.06

-0.8800-6.31%

Post-market: 12.81-0.2500-1.91%19:30 EDT

Volume:196.65K

Turnover:2.64M

Market Cap:643.18M

PE:-2.89

High:14.10

Open:14.00

Low:12.96

Close:13.94

52wk High:17.82

52wk Low:8.75

Shares:49.25M

Float Shares:13.84M

Volume Ratio:0.90

T/O Rate:1.42%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.5143

EPS(LYR):-168.1598

ROE:-39.22%

ROA:-20.58%

PB:5.99

PE(LYR):-0.08

Loading ...

Overview Company News Filings

Agomab Adds Marino Garcia, Naimish Patel to Board

Agomab Announces Appointments of Marino Garcia and DR. Naimish Patel to Board of Directors

THOMSON REUTERS

Press Release: Agomab Announces Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors

Agomab Therapeutics to Join Citi Biopharma Back to School Investor Conference

Piper Sandler Initiates Coverage on AgomAb Therapeutics With Overweight Rating

MT Newswires Live

AgomAb Therapeutics Price Target Announced at $60.00/Share by Piper Sandler

Agomab Therapeutics Nv : Piper Sandler Initiates Coverage with Overweight Rating; Target Price $60

THOMSON REUTERS

Cantor Fitzgerald Initiates AgomAb Therapeutics at Overweight

MT Newswires Live

AgomAb Therapeutics Initiated at Overweight by Cantor Fitzgerald

Agomab initiated with an Overweight at Cantor Fitzgerald

Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE), AgomAb Therapeutics NV ADR (AGMB) and Sana Biotechnology (SANA)

Agomab Therapeutics Shareholders Vote on Director Nominees Marino Garcia, Naimish Patel at Sept. 11 Meeting

Agomab Therapeutics Announces Shareholder Meetings

Agomab Announces Proposed Appointments of Marino Garcia and DR. Naimish Patel to Board of Directors

THOMSON REUTERS

Press Release: Agomab Announces Proposed Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors

AgomAb Therapeutics H1 EPS $(0.93)

Benzinga Earnings

Agomab FY26 H1 Net Loss Widens to €30.97 Million

Agomab Reports Half Year 2026 Financial Results and Confirms 2026 Outlook

THOMSON REUTERS

Agomab Therapeutics Initiated at Buy by B. Riley Securities

B. Riley Initiates AgomAb Therapeutics at Buy With $34 Price Target

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/AGMB/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"AGMB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGMB\",,,,,undefined,":{"symbol":"AGMB","market":"US","secType":"STK","nameCN":"AgomAb Therapeutics","latestPrice":13.06,"timestamp":1789156800000,"preClose":13.94,"halted":0,"volume":196653,"hourTrading":{"tag":"盘后","latestPrice":12.81,"preClose":13.06,"latestTime":"19:30 EDT","volume":107,"amount":1372.17,"timestamp":1789169407302,"change":-0.25,"changeRate":-0.019142,"amplitude":0.019142},"delay":0,"changeRate":-0.06312769010043034,"floatShares":13836000,"shares":49248000,"eps":-4.51426,"marketStatus":"Market Closed","change":-0.88,"latestTime":"09-11 16:00:00 EDT","open":14,"high":14.1,"low":12.96,"amount":2639111.381379,"amplitude":0.081779,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.51426,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"listingDate":1770354000000,"exchange":"NASDAQ","adjPreClose":13.94,"preHourTrading":{"tag":"盘前","latestPrice":13.88,"preClose":13.94,"latestTime":"07:57 EDT","volume":3,"amount":41.64,"timestamp":1789127822732,"change":-0.06,"changeRate":-0.004304,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":12.81,"preClose":13.06,"latestTime":"19:30 EDT","volume":107,"amount":1372.17,"timestamp":1789169407302,"change":-0.25,"changeRate":-0.019142,"amplitude":0.019142},"volumeRatio":0.8993156799938643},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGMB\",,,,,undefined,":{"symbol":"AGMB","floatShares":13836000,"roa":"-20.58%","roe":"-39.22%","lyrEps":-168.159829,"volumeRatio":0.8993156799938643,"shares":49248000,"dividePrice":0,"high":14.1,"amplitude":0.081779,"preClose":13.94,"low":12.96,"week52Low":8.75,"pbRate":"5.99","week52High":17.82,"institutionHeld":0,"latestPrice":13.06,"eps":-4.51426,"divideRate":0,"volume":196653,"delay":0,"ttmEps":-4.51426,"open":14,"prevYearClose":16,"prevWeekClose":15.78,"prevMonthClose":13.17,"prevQuarterClose":12.98,"fiveDayClose":14.83,"twentyDayClose":13.945,"sixtyDayClose":10},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AGMB\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AGMB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AGMB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":8,"updateTime":1787716800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AGMB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AGMB","date":"2026-09-11","current":-2.893054,"percent":0.527027,"low":-14.725744,"twenty":-11.959423,"median":-8.973278,"eighty":-7.956453,"high":-6.52172,"avg":-9.611341,"sd":2.194544,"marketCap":686516771},"quantilePoints":[{"date":"2026-02-06","current":-14.293959,"twenty":-14.293959,"median":-14.293959,"eighty":-14.293959,"marketCap":779788464},{"date":"2026-02-13","current":-13.901135,"twenty":-14.202947,"median":-13.85921,"eighty":-13.805127,"marketCap":763217959},{"date":"2026-02-20","current":-13.975141,"twenty":-14.020702,"median":-13.811207,"eighty":-13.436782,"marketCap":760781120},{"date":"2026-02-27","current":-14.297833,"twenty":-14.274685,"median":-13.837477,"eighty":-13.631029,"marketCap":780275831},{"date":"2026-03-06","current":-12.944797,"twenty":-14.315694,"median":-13.869306,"eighty":-13.479283,"marketCap":692549629},{"date":"2026-03-13","current":-12.71107,"twenty":-14.294734,"median":-13.805127,"eighty":-12.961754,"marketCap":677928595},{"date":"2026-03-20","current":-11.600011,"twenty":-14.274685,"median":-13.584093,"eighty":-12.695924,"marketCap":618957093},{"date":"2026-03-27","current":-10.84065,"twenty":-14.216331,"median":-13.160447,"eighty":-12.395453,"marketCap":578505566},{"date":"2026-04-02","current":-10.748527,"twenty":-14.066263,"median":-13.052487,"eighty":-11.414439,"marketCap":574119256},{"date":"2026-04-10","current":-9.193391,"twenty":-13.930737,"median":-12.827934,"eighty":-10.709469,"marketCap":497602513},{"date":"2026-04-17","current":-10.018749,"twenty":-13.86294,"median":-12.650405,"eighty":-9.901184,"marketCap":545851924},{"date":"2026-04-24","current":-9.622204,"twenty":-13.825362,"median":-12.457995,"eighty":-9.650988,"marketCap":521483535},{"date":"2026-05-01","current":-7.206485,"twenty":-13.809991,"median":-11.744798,"eighty":-9.486381,"marketCap":528794052},{"date":"2026-05-08","current":-7.639457,"twenty":-13.779732,"median":-11.111376,"eighty":-9.258769,"marketCap":562411874},{"date":"2026-05-15","current":-7.446972,"twenty":-13.702513,"median":-10.748527,"eighty":-8.300034,"marketCap":543697644},{"date":"2026-05-22","current":-7.434647,"twenty":-13.568448,"median":-10.364346,"eighty":-8.115636,"marketCap":538772846},{"date":"2026-05-29","current":-7.796965,"twenty":-13.4527,"median":-9.998785,"eighty":-7.794875,"marketCap":568321631},{"date":"2026-06-05","current":-8.053102,"twenty":-13.287949,"median":-9.784729,"eighty":-7.758816,"marketCap":585558422},{"date":"2026-06-12","current":-6.750851,"twenty":-13.127527,"median":-9.578953,"eighty":-7.536224,"marketCap":486569993},{"date":"2026-06-18","current":-6.929006,"twenty":-13.073014,"median":-9.501773,"eighty":-7.448225,"marketCap":497404547},{"date":"2026-06-26","current":-9.2886,"twenty":-13.035188,"median":-9.467948,"eighty":-7.458553,"marketCap":661400304},{"date":"2026-07-02","current":-8.166663,"twenty":-12.965993,"median":-9.467948,"eighty":-7.479819,"marketCap":584573463},{"date":"2026-07-10","current":-8.975013,"twenty":-12.944797,"median":-9.309036,"eighty":-7.532768,"marketCap":641701114},{"date":"2026-07-17","current":-8.479177,"twenty":-12.71107,"median":-9.193391,"eighty":-7.541408,"marketCap":606735052},{"date":"2026-07-24","current":-8.981683,"twenty":-12.707304,"median":-9.020605,"eighty":-7.554336,"marketCap":638746235},{"date":"2026-07-31","current":-8.723327,"twenty":-12.661785,"median":-8.978348,"eighty":-7.610114,"marketCap":628157921},{"date":"2026-08-07","current":-9.22434,"twenty":-12.557349,"median":-9.00807,"eighty":-7.636377,"marketCap":664847662},{"date":"2026-08-14","current":-8.931525,"twenty":-12.519309,"median":-9.035172,"eighty":-7.716456,"marketCap":686763011},{"date":"2026-08-21","current":-8.496488,"twenty":-12.423423,"median":-8.981683,"eighty":-7.781927,"marketCap":661400304},{"date":"2026-08-28","current":-8.778373,"twenty":-12.380686,"median":-8.974146,"eighty":-7.796268,"marketCap":681591974},{"date":"2026-09-04","current":-9.428222,"twenty":-12.300242,"median":-8.931525,"eighty":-7.867232,"marketCap":730347469},{"date":"2026-09-11","current":-8.858281,"twenty":-11.959423,"median":-8.973278,"eighty":-7.956453,"marketCap":686516771}],"updateTime":1789322063910},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AGMB\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666571437","title":"Agomab Adds Marino Garcia, Naimish Patel to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2666571437","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666571437?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:05","pubTimestamp":1789157125,"startTime":"0","endTime":"0","summary":"Agomab adds Marino Garcia, Naimish Patel to boardAgomab shareholders appointed Marino Garcia as a non-executive director at a special meeting on Sept. 11, 2026.Dr. Naimish Patel also joined the board ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL4STDmG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","SG9999014005.SGD","BK4585","LU2210149790.SGD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","NDAQ","BK4112","BCDF","SG9999014039.USD","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","LU0314104364.USD","IE00BN0W2V16.EUR","LU2210150020.SGD","IE00BN0W2T93.GBP","SG9999014021.USD","IE00BKPKM429.USD","AGMB","SG9999014013.SGD","IE00BQXX3C00.GBP","BK4588","IE00B3QW5Z07.USD","BK4007","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666571435","title":"Agomab Announces Appointments of Marino Garcia and DR. Naimish Patel to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666571435","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666571435?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:05","pubTimestamp":1789157101,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nTUA6MDXLM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AGMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666571466","title":"Press Release: Agomab Announces Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666571466","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666571466?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:05","pubTimestamp":1789157100,"startTime":"0","endTime":"0","summary":"Antwerp, Belgium, September 11, 2026 -- Agomab Therapeutics NV (Nasdaq: AGMB) (\"Agomab\" or the \"Company\"), a clinical-stage biopharmaceutical company focused on fibro-inflammatory diseases, today anno","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AGMB","IPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664809790","title":"Agomab Therapeutics to Join Citi Biopharma Back to School Investor Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664809790","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664809790?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:05","pubTimestamp":1788465919,"startTime":"0","endTime":"0","summary":"Agomab Therapeutics to join Citi Biopharma Back to School investor conferenceAgomab management will attend investor conferences in New York on Sept. 10-16, 2026.Schedule includes Citi’s Biopharma Back","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL63f6xR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106261372.USD","LU2125154935.USD","LU0912757837.SGD","LU0971096721.USD","SG9999014013.SGD","LU1064131342.USD","LU2133065610.SGD","BK4559","LU0528227936.USD","LU0390134368.USD","IYF","IE00BN0W2W23.USD","IE00BKPKM429.USD","LU0314104364.USD","LU1506573853.SGD","LU1244550494.USD","LU1244550577.SGD","BCDF","AGMB","IE00BSNM7G36.USD","LU0130517989.USD","IAI","IE00BN0W2V16.EUR","BK4581","LU0130102774.USD","KBWB","LU0267386448.USD","LU2417539215.USD","NDAQ","BK4566","FTXO","LU2023251221.USD","LU0648001328.SGD","LU2357305700.SGD","LU2028103732.USD","LU2487616109.SGD","LU0795875169.SGD","LU1988902786.USD","BK4207","LU2095319765.USD","LU1732800096.USD","LU0234570918.USD","LU0795875086.SGD","LU1989772840.SGD","BK4112","IE00BQXX3D17.EUR","TFNS","LU1267930227.SGD","IE00BZ1G4Q59.USD","LU2264538146.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662573600","title":"Piper Sandler Initiates Coverage on AgomAb Therapeutics With Overweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2662573600","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662573600?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:06","pubTimestamp":1787655998,"startTime":"0","endTime":"0","summary":"Piper Sandler Initiates Coverage on AgomAb Therapeutics With Overweight Rating","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AGMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662384327","title":"AgomAb Therapeutics Price Target Announced at $60.00/Share by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2662384327","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662384327?lang=en_us&edition=fundamental","pubTime":"2026-08-25 17:51","pubTimestamp":1787651460,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AGMB/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662781274","title":"Agomab Therapeutics Nv : Piper Sandler Initiates Coverage with Overweight Rating; Target Price $60","url":"https://stock-news.laohu8.com/highlight/detail?id=2662781274","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662781274?lang=en_us&edition=fundamental","pubTime":"2026-08-25 15:32","pubTimestamp":1787643147,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nFWN44L0TQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AGMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660442456","title":"Cantor Fitzgerald Initiates AgomAb Therapeutics at Overweight","url":"https://stock-news.laohu8.com/highlight/detail?id=2660442456","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660442456?lang=en_us&edition=fundamental","pubTime":"2026-08-19 18:47","pubTimestamp":1787136420,"startTime":"0","endTime":"0","summary":"AgomAb Therapeutics (AGMB) has an average rating of buy and mean price target of $33.29, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AGMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660244248","title":"AgomAb Therapeutics Initiated at Overweight by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2660244248","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660244248?lang=en_us&edition=fundamental","pubTime":"2026-08-19 18:45","pubTimestamp":1787136300,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AGMB/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660444293","title":"Agomab initiated with an Overweight at Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2660444293","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660444293?lang=en_us&edition=fundamental","pubTime":"2026-08-19 18:15","pubTimestamp":1787134507,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald analyst Yanni Souroutzidis initiated coverage of Agomab (AGMB) with an Overweight rating. Published first on TheFly – the ultimat...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/agomab-initiated-with-an-overweight-at-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/agomab-initiated-with-an-overweight-at-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGMB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660480044","title":"Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE), AgomAb Therapeutics NV ADR (AGMB) and Sana Biotechnology (SANA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660480044","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660480044?lang=en_us&edition=fundamental","pubTime":"2026-08-17 21:01","pubTimestamp":1786971667,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Fortrea Holdings Inc. (FTRE), AgomAb Therapeutics NV...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-fortrea-holdings-inc-ftre-agomab-therapeutics-nv-adr-agmb-and-sana-biotechnology-sana-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-fortrea-holdings-inc-ftre-agomab-therapeutics-nv-adr-agmb-and-sana-biotechnology-sana-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FTRE","CVY","BK4007","APIE","BK4139","ARMH","HCSG","DIVL","BK4121","BK4585","BK4581","LU0029874061.USD","BK4137","SAPH","DINT","XLV","BK4588","XBI","AADR","LU0128526141.USD","AGMB","SANA","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658883954","title":"Agomab Therapeutics Shareholders Vote on Director Nominees Marino Garcia, Naimish Patel at Sept. 11 Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2658883954","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658883954?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:46","pubTimestamp":1786394787,"startTime":"0","endTime":"0","summary":"Agomab Therapeutics shareholders vote on director nominees Marino Garcia, Naimish Patel at Sept. 11 meetingAgomab Therapeutics shareholders will vote Sept. 11, 2026 on adding two non-executive directo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDLPMSvd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGMB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658595978","title":"Agomab Therapeutics Announces Shareholder Meetings","url":"https://stock-news.laohu8.com/highlight/detail?id=2658595978","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658595978?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:19","pubTimestamp":1786393162,"startTime":"0","endTime":"0","summary":"Agomab Therapeutics announces shareholder meetingsAgomab will hold a Special General Meeting in Antwerp, Belgium on Sept. 11, 2026.Shareholders will vote on proposed appointments of Marino Garcia and ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDLbNgrln:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","LU0314104364.USD","NDAQ","SG9999014013.SGD","AGMB","IE00BN0W2T93.GBP","BK4112","BCDF","IE00BKPKM429.USD","BK4007","LU2095319765.USD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","BK4585","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","SG9999014039.USD","SG9999014005.SGD","IE00BN0W2W23.USD","LU2210149790.SGD","SG9999014021.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658846959","title":"Agomab Announces Proposed Appointments of Marino Garcia and DR. Naimish Patel to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2658846959","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658846959?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:07","pubTimestamp":1786392435,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUABJ4SDW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AGMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658596039","title":"Press Release: Agomab Announces Proposed Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2658596039","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658596039?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:07","pubTimestamp":1786392420,"startTime":"0","endTime":"0","summary":"approval at the Company's Special General Meeting to be held on September. -- The Company also announced that it will hold an Extraordinary General. Shareholders' Meeting to obtain shareholder approval for the proposed","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGMB","IPO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657666647","title":"AgomAb Therapeutics H1 EPS $(0.93)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657666647","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657666647?lang=en_us&edition=fundamental","pubTime":"2026-08-07 05:52","pubTimestamp":1786053125,"startTime":"0","endTime":"0","summary":"AgomAb Therapeutics (NASDAQ:AGMB) reported quarterly losses of $(0.93) per share.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61026366/agomab-therapeutics-h1-eps-0-93","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"AgomAb Therapeutics H1 EPS $(0.93)","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657756652","title":"Agomab FY26 H1 Net Loss Widens to €30.97 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657756652","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657756652?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:02","pubTimestamp":1786046565,"startTime":"0","endTime":"0","summary":"Agomab FY26 H1 net loss widens to 30.97 millionAgomab posted a net loss of EUR 31 million for the six months ended June 30, 2026, widening from EUR 26.9 million a year earlier.R&D expense edged up to ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL92jydC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","BK4112","LU2210149790.SGD","LU2095319765.USD","BK4588","LU0314104364.USD","IE00BKPKM429.USD","SG9999014039.USD","BCDF","AGMB","IE00B64PRP62.GBP","IE00BGHQF748.EUR","BK4585","NDAQ","BK4007","SG9999014013.SGD","SG9999014005.SGD","SG9999014021.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657652239","title":"Agomab Reports Half Year 2026 Financial Results and Confirms 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2657652239","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657652239?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:01","pubTimestamp":1786046461,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nTUA12YZKW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AGMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653726762","title":"Agomab Therapeutics Initiated at Buy by B. Riley Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2653726762","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653726762?lang=en_us&edition=fundamental","pubTime":"2026-07-23 22:24","pubTimestamp":1784816640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AGMB/analyst-ratings(END) Dow Jones NewswiresJuly 23, 2026 10:24 ET","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4007","LENZ","AGMB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653975740","title":"B. Riley Initiates AgomAb Therapeutics at Buy With $34 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2653975740","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653975740?lang=en_us&edition=fundamental","pubTime":"2026-07-23 20:22","pubTimestamp":1784809320,"startTime":"0","endTime":"0","summary":"AgomAb Therapeutics NV ADR (AGMB) has an average rating of buy and mean price target of $32.53, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fro","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AGMB"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":48,"code":"91000000","status":"200"}]}}